COMMUNIQUÉS West-GlobeNewswire

-
Predictive Technology Group Reports Third Quarter Fiscal 2019 Financial Results
21/05/2019 -
DiaMedica Therapeutics Announces Formation of Scientific Advisory Board for Kidney Disease
21/05/2019 -
Marrone Bio Innovations to Present at the 9th Annual LD Micro Invitational Investor Conference in Los Angeles on Tuesday, June 4th
21/05/2019 -
Adamis Pharmaceuticals Announces Patent Litigation Regarding Its Higher Dose Naloxone Injection Product
21/05/2019 -
Assure Holdings Sets First Quarter 2019 Conference Call for Wednesday, May 29, 2019, at 11:00 a.m. ET
21/05/2019 -
Bellerophon Presents Additional Positive Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at American Thoracic Society 115th International Conference
21/05/2019 -
Seelos Therapeutics Reports Q1 2019 Pipeline Update
21/05/2019 -
HIV Cure Program Patent Granted To American Gene Technologies
21/05/2019 -
Vaxil Granted Significant US Patent for Anti-Infective Vaccines
21/05/2019 -
BioSyent Schedules Q1 2019 Earnings Release for May 29, 2019
21/05/2019 -
Matinas BioPharma Announces Abstract Accepted for Presentation at ASM Microbe 2019
21/05/2019 -
Todos Medical Enters Exclusive Distribution Agreement with Care G.B. Plus, Ltd. for its Breast Cancer Screening Tests in Israel
21/05/2019 -
Precision Therapeutics’ Helomics Division Selected by AccuGenomics as Preferred Lab Partner for NIIMBL Grant
21/05/2019 -
Apotheca Biosciences’ (CBDC) Distribution of ProMED’s Pharma Grade CBD Products Receives Great Response -- Company in Discussion with Wholesalers for Mass Distribution of ProMED CBD Product Lines for an Initial 500 Outlets Nationally
21/05/2019 -
Progressive Care Inc. Announces April Sales & Record Breaking Month
21/05/2019 -
Quotient Ltd. Announces FDA Approval of Seven Additional Blood Bank Reagents
21/05/2019 -
Protech Home Medical Reports Solid Second Quarter Fiscal 2019 Financial Results
21/05/2019 -
Abeona Therapeutics Announces FDA Clearance of Investigational New Drug Application for ABO-202 Gene Therapy in CLN1 Disease
21/05/2019 -
PSIQ Reports Record Breaking Revenue Increase of Almost 120% for Its Hemp Derived CBD Product Line
21/05/2019
Pages